デフォルト表紙
市場調査レポート
商品コード
1633589

細菌細胞培養の市場規模、シェア、成長分析:製品タイプ別、用途別、対象者別、エンドユーザー別、地域別 - 産業予測、2025年~2032年

Bacterial Cell Culture Market Size, Share, Growth Analysis, By Product Type (Media, Reagents), By Application (Pharmaceutical and Biotechnology, Research and Academic), By Targeted Audience, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 201 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
細菌細胞培養の市場規模、シェア、成長分析:製品タイプ別、用途別、対象者別、エンドユーザー別、地域別 - 産業予測、2025年~2032年
出版日: 2025年01月13日
発行: SkyQuest
ページ情報: 英文 201 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細菌細胞培養の世界市場規模は2023年に31億7,000万米ドルとなり、予測期間(2025-2032年)のCAGRは6.6%で、2024年の33億8,000万米ドルから2032年には56億3,000万米ドルに成長する見通しです。

2023年10月現在、世界の細菌細胞培養市場は、研究、分析、バイオ医薬品開発における多様なアプリケーションに牽引され、大きな成長を遂げています。この市場には、細菌細胞培養培地、試薬、必須機器などの主要コンポーネントが含まれ、市場金額で分析され、国別にセグメント化されています。発酵食品の消費の急増は、保存期間の延長や官能特性の向上以上の利点が認められており、この市場をさらに活性化させています。乳酸菌(LAB)と酵母は、様々な発酵製品において極めて重要なスターターカルチャーであり、その中でも乳培養が突出しています。特に、中国、インド、より広いアジアおよび中東市場といった地域が、細菌細胞培養アプリケーションの革新と拡大のホットスポットとして浮上しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 技術の進歩
  • 規制情勢
  • 特許分析

細菌細胞培養市場規模:製品タイプ別& CAGR(2025-2032)

  • 市場概要
  • メディア
    • 複合メディア
    • 定義されたメディア
  • 試薬
    • 血清
    • バッファー
    • 抗生物質
  • 機器
    • バイオリアクター
    • インキュベーター
    • 遠心分離機

細菌細胞培養市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 製薬およびバイオテクノロジー
    • 医薬品開発
    • ワクチン製造
  • 調査と学術
    • 微生物遺伝学
    • タンパク質発現研究
  • 食品・飲料
    • 品質管理
    • 発酵プロセス
  • その他

細菌細胞培養市場規模:対象者別& CAGR(2025-2032)

  • 市場概要
  • 細胞培養培地製造会社
  • ヘルスケア機関
  • ヘルスケア提供者
  • 政府機関
  • 契約製造組織(CMO)
  • 研究開発(R&D)企業

細菌細胞培養市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 診断センター
  • 食品産業
  • その他

細菌細胞培養市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Thermo Fisher Scientific Inc.(United States)
  • Merck KGaA(Germany)
  • Becton, Dickinson and Company(United States)
  • bioMerieux S.A.(France)
  • Bio-Rad Laboratories, Inc.(United States)
  • Danaher Corporation(United States)
  • Lonza Group AG(Switzerland)
  • Sartorius AG(Germany)
  • Neogen Corporation(United States)
  • Agilent Technologies, Inc.(United States)
  • GE Healthcare(United States)
  • Eiken Chemical Co., Ltd.(Japan)
  • Scharlab S.L.(Spain)
  • HiMedia Laboratories Pvt. Ltd.(India)
  • ScienCell Research Laboratories, Inc.(United States)
  • Advanced Instruments(United States)
  • Bio-Techne Corporation(United States)
  • Takara Bio Inc.(Japan)
  • Corning Incorporated(United States)

結論と推奨事項

目次
Product Code: SQMIG35A2811

Global Bacterial Cell Culture Market size was valued at USD 3.17 billion in 2023 and is poised to grow from USD 3.38 billion in 2024 to USD 5.63 billion by 2032, growing at a CAGR of 6.6% during the forecast period (2025-2032).

As of October 2023, the global bacterial cell culture market is witnessing significant growth, driven by diverse applications in research, analysis, and biopharmaceutical development. This market encompasses key components such as bacterial cell culture media, reagents, and essential equipment, analyzed by market value and segmented by country. The surge in fermented food consumption, recognized for its benefits beyond extended shelf life and enhanced sensory properties, further fuels this market. Lactic acid bacteria (LAB) and yeasts are pivotal starter cultures in various fermented products, with milk cultures leading in prominence. Notably, regions like China, India, and the broader Asian and Middle Eastern markets are emerging as hotspots for innovation and expansion in bacterial cell culture applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bacterial Cell Culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bacterial Cell Culture Market Segmental Analysis

Global Bacterial Cell Culture Market is segmented by Product Type, Application, Targeted Audience, End User and region. Based on Product Type, the market is segmented into Media, Reagents and Instruments. Based on Application, the market is segmented into Pharmaceutical and Biotechnology, Research and Academic, Food and Beverage and Other. Based on Targeted Audience, the market is segmented into Cell culture media manufacturing companies, Healthcare organizations, Healthcare providers, Government organizations, Contract manufacturing organization (CMO) and Research and development (R&D) companies. Based on End User, the market is segmented into Diagnostic Centers, Food Industry and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bacterial Cell Culture Market

The global bacterial cell culture market is experiencing significant growth, primarily fueled by the rising demand for bacterial cell cultures essential in the development of various pharmaceuticals, including antibiotics, hormones, vaccines, and insulin. The expansion in the production of natural drugs, particularly those involving genetically engineered protein transformations and other macromolecules, serves as a critical impetus for this market. These advanced therapeutic agents have shown efficacy in addressing several medical conditions, such as liver disease and chronic asthma. As a result, the increasing need for innovative drugs is expected to propel the bacterial cell culture market to new heights in the coming years.

Restraints in the Global Bacterial Cell Culture Market

The Global Bacterial Cell Culture market faces notable restraints primarily related to contamination risks and ethical dilemmas. The intricate nature of bacterial cell culture systems necessitates rigorous cleaning protocols to prevent contamination and ensure the purity of cultures. Any contamination poses serious risks, potentially diminishing activity in various applications and elevating costs associated with animal-derived products in the pharmaceutical sector. Moreover, ethical issues linked to the use of animal products further complicate market growth. Consequently, there's been a significant trend toward adopting alternative methods that do not rely on animal products, addressing both contamination concerns and ethical considerations while fostering market sustainability.

Market Trends of the Global Bacterial Cell Culture Market

The Global Bacterial Cell Culture market is witnessing significant growth driven by the burgeoning biopharmaceutical sector, where bacterial cells are pivotal in producing a multitude of essential drugs, including antibiotics, hormones, vaccines, and insulin. This trend is amplified by rising global health concerns, especially the escalating prevalence of antibiotic-resistant microorganisms, prompting intensified research into innovative therapeutic solutions such as bacteriophage therapy. Additionally, advancements in genetic engineering and biotechnology are further propelling the market, as they enhance the efficacy of bacterial cultures in drug development. Overall, the integration of bacterial cell cultures in therapeutics is anticipated to foster robust market expansion in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape
  • Patent Analysis

Global Bacterial Cell Culture Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Media
    • Complex Media
    • Defined Media
  • Reagents
    • Serum
    • Buffers
    • Antibiotics
  • Instruments
    • Bioreactors
    • Incubators
    • Centrifuges

Global Bacterial Cell Culture Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical and Biotechnology
    • Drug Development
    • Vaccine Production
  • Research and Academic
    • Microbial Genetics
    • Protein Expression Studies
  • Food and Beverage
    • Quality Control
    • Fermentation Processes
  • Other

Global Bacterial Cell Culture Market Size by Targeted Audience & CAGR (2025-2032)

  • Market Overview
  • Cell culture media manufacturing companies
  • Healthcare organizations
  • Healthcare providers
  • Government organizations
  • Contract manufacturing organization (CMO)
  • Research and development (R&D) companies

Global Bacterial Cell Culture Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Diagnostic Centers
  • Food Industry
  • Others

Global Bacterial Cell Culture Market Size & CAGR (2025-2032)

  • North America (Product Type, Application, Targeted Audience, End User)
    • US
    • Canada
  • Europe (Product Type, Application, Targeted Audience, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Application, Targeted Audience, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Application, Targeted Audience, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Application, Targeted Audience, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eiken Chemical Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Scharlab S.L. (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiMedia Laboratories Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ScienCell Research Laboratories, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Instruments (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corning Incorporated (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations